PHILADELPHIA – Palliative Connect, a trigger system developed at Penn Medicine and powered by predictive analytics, was found to be effective at increasing palliative care consultations for seriously ill patients, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania. After the system was implemented, palliative care consultation increased by 74 percent. The study was published this month in the Journal of General Internal Medicine.
“There’s widespread recognition of the need to improve the quality of palliative care for seriously ill patients, and palliative care consultation has been associated with improved outcomes for these patients,” said the study’s lead author, Katherine Courtright, MD, an assistant professor of Pulmonary, Allergy and Critical Care, and Hospice and Palliative Medicine.
According to the Center to Advance Palliative Care, palliative care is specialized medical care focused on providing relief from the symptoms and stress of a serious illness to improve the quality of life for patients and families. Palliative care is appropriate for patients of any age and during any stage of illness, which distinguishes it from hospice care, which takes place near the end of life.
Palliative Connect draws on clinical data from the electronic health record and uses machine learning to develop a score based on 30 different factors of a person’s likely prognosis over six months—the timeframe doctors are asked to use when making a decision on whether palliative care consultation would be beneficial.
The study team, which was also led by study senior author Nina O’Connor, MD, the chief of Palliative Care at Penn Medicine, evaluated Palliative Connect over an eight-week period between December 2017 and February 2018. In that span, 134 patients who’d been admitted to a Philadelphia hospital were compared to a similar population of 138 patients selected from a time before Palliative Connect was applied.
In the group of patients from when Palliative Connect was applied, consultations increased significantly, climbing from 22 to 85. Additionally, patients were seen by palliative care earlier in their hospital stay – an average of a day and a half sooner.
However, primary team physicians were able to decline triggered consultations, and the researchers found that about 43 percent did so. The authors note that there were several reasons provided by the primary teams for declining a triggered consult. These included the primary team feeling that they are already meeting the patient’s needs, or that the patient doesn’t have any palliative care needs at the time. These explanations, Courtright said, highlight the fact that prognosis isn’t a perfect measure of palliative care needs for every patient — it’s just one aspect of serious illness.
The study also showed that none of the patients or their caregivers declined a triggered consultation after it was accepted by the primary team physician.
“This approach helps us get a foot in the door and really explain what palliative care is to patients and their families,” Courtright explained. “Sometimes, there is this sense from primary teams that patients or families are hesitant or don’t want to talk about palliative care, but, when a palliative care clinician walks into the room and explains what they do, often people really are glad to see us there.”
The researchers believe this the first time a scalable, data-driven prediction system of this kind has been tested in a real clinical setting for palliative care. There have been other palliative care triggers used, but few that have been developed from empirical evidence, and even fewer that have been rigorously tested.
Moving forward, the researchers plan to continue fine-tuning the Palliative Connect prediction model. Additionally, another study is underway to gauge the perspective of physicians, patients, and palliative care clinicians on consult triggers to better inform future use of such interventions.
“Our goal is for every seriously ill patient to have a conversation with their clinician about their priorities and wishes, and to document those priorities in the medical record,” O’Connor said. “We think that triggers are allowing us to do that, so we’ll continue to evaluate and refine in order to help more patients.”
This study was funded in part through the National Palliative Care Research Center.
Other Penn authors include Michael Draugelis; Corey Chivers, PHD; Michael Becker; Susan Regli, PhD; and Linnea Pepper, MD.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $425 million awarded in the 2018 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Home Care and Hospice Services, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 40,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2018, Penn Medicine provided more than $525 million to benefit our community.